S&P 500   4,291.38 (+0.08%)
DOW   33,453.07 (-0.16%)
QQQ   362.42 (+1.16%)
AAPL   174.18 (+1.73%)
MSFT   321.23 (+1.74%)
META   306.65 (+2.15%)
GOOGL   134.16 (+2.52%)
AMZN   130.30 (+2.50%)
TSLA   253.66 (+1.37%)
NVDA   451.15 (+3.72%)
NIO   8.84 (-2.21%)
BABA   86.45 (-0.33%)
AMD   103.20 (+0.37%)
T   14.89 (-0.87%)
F   12.33 (-0.72%)
MU   68.09 (+0.09%)
CGC   0.79 (+1.32%)
GE   109.52 (-0.93%)
DIS   81.37 (+0.39%)
AMC   7.96 (-0.38%)
PFE   33.43 (+0.78%)
PYPL   58.96 (+0.86%)
NFLX   383.48 (+1.56%)
S&P 500   4,291.38 (+0.08%)
DOW   33,453.07 (-0.16%)
QQQ   362.42 (+1.16%)
AAPL   174.18 (+1.73%)
MSFT   321.23 (+1.74%)
META   306.65 (+2.15%)
GOOGL   134.16 (+2.52%)
AMZN   130.30 (+2.50%)
TSLA   253.66 (+1.37%)
NVDA   451.15 (+3.72%)
NIO   8.84 (-2.21%)
BABA   86.45 (-0.33%)
AMD   103.20 (+0.37%)
T   14.89 (-0.87%)
F   12.33 (-0.72%)
MU   68.09 (+0.09%)
CGC   0.79 (+1.32%)
GE   109.52 (-0.93%)
DIS   81.37 (+0.39%)
AMC   7.96 (-0.38%)
PFE   33.43 (+0.78%)
PYPL   58.96 (+0.86%)
NFLX   383.48 (+1.56%)
S&P 500   4,291.38 (+0.08%)
DOW   33,453.07 (-0.16%)
QQQ   362.42 (+1.16%)
AAPL   174.18 (+1.73%)
MSFT   321.23 (+1.74%)
META   306.65 (+2.15%)
GOOGL   134.16 (+2.52%)
AMZN   130.30 (+2.50%)
TSLA   253.66 (+1.37%)
NVDA   451.15 (+3.72%)
NIO   8.84 (-2.21%)
BABA   86.45 (-0.33%)
AMD   103.20 (+0.37%)
T   14.89 (-0.87%)
F   12.33 (-0.72%)
MU   68.09 (+0.09%)
CGC   0.79 (+1.32%)
GE   109.52 (-0.93%)
DIS   81.37 (+0.39%)
AMC   7.96 (-0.38%)
PFE   33.43 (+0.78%)
PYPL   58.96 (+0.86%)
NFLX   383.48 (+1.56%)
S&P 500   4,291.38 (+0.08%)
DOW   33,453.07 (-0.16%)
QQQ   362.42 (+1.16%)
AAPL   174.18 (+1.73%)
MSFT   321.23 (+1.74%)
META   306.65 (+2.15%)
GOOGL   134.16 (+2.52%)
AMZN   130.30 (+2.50%)
TSLA   253.66 (+1.37%)
NVDA   451.15 (+3.72%)
NIO   8.84 (-2.21%)
BABA   86.45 (-0.33%)
AMD   103.20 (+0.37%)
T   14.89 (-0.87%)
F   12.33 (-0.72%)
MU   68.09 (+0.09%)
CGC   0.79 (+1.32%)
GE   109.52 (-0.93%)
DIS   81.37 (+0.39%)
AMC   7.96 (-0.38%)
PFE   33.43 (+0.78%)
PYPL   58.96 (+0.86%)
NFLX   383.48 (+1.56%)
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Forecast, Price & News

$67.80
-1.22 (-1.77%)
(As of 11:21 AM ET)
Compare
Today's Range
$67.40
$68.86
50-Day Range
$63.36
$81.53
52-Week Range
$54.66
$85.62
Volume
71,164 shs
Average Volume
298,360 shs
Market Capitalization
$3.91 billion
P/E Ratio
43.46
Dividend Yield
N/A
Price Target
$87.83

Merit Medical Systems MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
27.8% Upside
$87.83 Price Target
Short Interest
Healthy
1.77% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
1.23mentions of Merit Medical Systems in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$2.08 M Sold Last Quarter
Proj. Earnings Growth
11.81%
From $2.88 to $3.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.90 out of 5 stars

Medical Sector

44th out of 969 stocks

Surgical & Medical Instruments Industry

8th out of 100 stocks


MMSI stock logo

About Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Price History

MMSI Stock News Headlines

Analyst Expectations for Merit Medical Systems's Future
Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
Expert Ratings for Merit Medical Systems
Barrington Keeps Their Buy Rating on Merit Medical Systems (MMSI)
The Latest Analyst Ratings for Merit Medical Systems
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

MMSI Company Calendar

Last Earnings
7/25/2023
Today
10/02/2023
Next Earnings (Estimated)
10/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,846
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$87.83
High Stock Price Forecast
$96.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+27.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$74.52 million
Pretax Margin
8.19%

Debt

Sales & Book Value

Annual Sales
$1.15 billion
Cash Flow
$4.37 per share
Book Value
$20.11 per share

Miscellaneous

Free Float
55,469,000
Market Cap
$3.98 billion
Optionable
Optionable
Beta
0.97

Social Links

10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Fred P. LampropoulosMr. Fred P. Lampropoulos (Age 73)
    Founder, Chairman, CEO & Pres
    Comp: $2.8M
  • Mr. Raul Parra Jr. (Age 45)
    CPA, CFO & Treasurer
    Comp: $928.35k
  • Mr. Neil Peterson (Age 57)
    Chief Operating Officer
    Comp: $1.02M
  • Mr. Brian G. LloydMr. Brian G. Lloyd (Age 62)
    Chief Legal Officer & Corp. Sec.
    Comp: $848.66k
  • Mr. Joseph C. WrightMr. Joseph C. Wright (Age 53)
    Chief Commercial Officer
    Comp: $970.59k
  • Mr. Jason Treft
    Chief Technology Officer
  • Mr. Joseph Pierce
    Chief Information Officer
  • Sarah Comstock
    VP of Global Communications
  • JoAnne Alkire
    Exec. VP of Global Marketing & Strategy
  • Mr. Michel J. Voigt (Age 50)
    Chief HR Officer













MMSI Stock - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price forecast for 2023?

5 analysts have issued 12-month price objectives for Merit Medical Systems' shares. Their MMSI share price forecasts range from $70.00 to $96.00. On average, they anticipate the company's share price to reach $87.83 in the next year. This suggests a possible upside of 27.3% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2023?

Merit Medical Systems' stock was trading at $70.62 at the start of the year. Since then, MMSI stock has decreased by 2.3% and is now trading at $69.02.
View the best growth stocks for 2023 here
.

When is Merit Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our MMSI earnings forecast
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its earnings results on Tuesday, July, 25th. The medical instruments supplier reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.06. The medical instruments supplier earned $320.06 million during the quarter, compared to analyst estimates of $310.10 million. Merit Medical Systems had a net margin of 7.48% and a trailing twelve-month return on equity of 14.60%. The company's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.73 EPS.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY23 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of $2.81-2.92 for the period, compared to the consensus EPS estimate of $2.90. The company issued revenue guidance of $1.230-1.244 billion, compared to the consensus revenue estimate of $1.23 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $69.02.

How much money does Merit Medical Systems make?

Merit Medical Systems (NASDAQ:MMSI) has a market capitalization of $3.98 billion and generates $1.15 billion in revenue each year. The medical instruments supplier earns $74.52 million in net income (profit) each year or $1.56 on an earnings per share basis.

How many employees does Merit Medical Systems have?

The company employs 6,846 workers across the globe.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The official website for the company is www.merit.com. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at awright@merit.com, or via fax at 801-253-1652.

This page (NASDAQ:MMSI) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -